{"database": "openregs", "table": "dockets", "rows": [["FDA-2026-P-12386", "FDA", "Requests that the FDA to determine whether the Reference Listed Drug (RLD) URSO 250 and URSO FORTE (Ursodiol) Tablets, 250 mg and 500 mg under New Drug Application (NDA) 020675 held by ABBVIE INC, was voluntarily withdrawn from commercial distribution, or withdrawn from sale for safety or efficacy reasons", "Nonrulemaking", "2026-10-14T11:22:05Z", "0b000064b9668e31", null, null, null, null, null, null, null, null, null, null, "list_pull"]], "columns": ["id", "agency_id", "title", "docket_type", "last_modified", "object_id", "rin", "dkabstract", "category", "subtype", "keywords", "program", "short_title", "effective_date", "organization", "attrs_raw", "attr_source"], "primary_keys": ["id"], "primary_key_values": ["FDA-2026-P-12386"], "units": {}, "query_ms": 0.2564430033089593, "source": "U.S. government sources, plus a few identifier registries; each is listed on the methodology page", "source_url": "https://datadawn.org/methodology#data", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}